dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Business Affairs Homepage

Air medical transportation: How a 15-minute ride may cost $30,000, and how we can change it Reducing sky-high transport expenses

Canon's Vital Images wins DoD contract Maximum $100 million fixed‐price contract for radiology and imaging systems

Are you GDPR compliant? It's not just a question for EU-based companies Here are the top eight considerations

Security tightening at hospitals for patient safety A noticeable change is occurring at the front entrance to hospitals

Johnson & Johnson completes Auris Health deal The $3.4 billion acquisition could include additional payments up to $2.35 billion

Follow-up imaging study points to benefits of automated notification Raising the bar on manual callbacks

Change Healthcare files for IPO Could raise as much as $100 million, listing on Nasdaq

Mergers do nothing for quality of care, lower patient satisfaction, says study Based on 29 data points and the assessment of 16 processes of care

GE Healthcare IPO on hold as new deal takes spotlight Selling biopharma business to Danaher for over $21 billion

Asheville Radiology Association joins Strategic Radiology The latest expansion by the imaging coalition brings 43 new physicians to the table

Merit Medical Systems closes acquisition
of Cianna Medical

Merit Medical Systems closes acquisition of Cianna Medical

by Thomas Dworetzky , Contributing Reporter
Merit Medical Systems has completed its acquisition of Cianna Medical.

“We are delighted to have Cianna Medical join the Merit family,” Merit Chairman and CEO Fred P. Lampropoulos said in a statement. “We are looking forward to continuing Cianna’s momentum, expanding internationally, and associating with Cianna Medical’s domestic sales and marketing team.”

Story Continues Below Advertisement

Free Marketplace where Lenders Compete Get Pre-Approved for up to $500,000

Get financing today. We say YES more! Easy, Fast, Application. Pick the payment that best works for you. Tax Benefits + Leasing = Huge Savings! NEVER BE OBSOLETE. NO DOWN PAYMENT. FIXED MONTHLY PAYMENT. MRI, CT, Ultrasound, Digital X-ray, Dental Equipment



The deal, a merger that leaves Cianna as a wholly-owned subsidiary of Merit, was for an upfront cash payment of $135 million with possible additional incentivized payments – $15 million for hitting supply chain and scalability goals and up to $50 million for reaching sales targets.

“Our companies share a rich history of developing technologies that put patients' needs first. Merit Medical brings exceptional resources to the Cianna Medical team that will intensify its growth and broaden its focus beyond breast cancer,” Cianna Medical president and CEO Jill Anderson said when the deal was announced in early October. “I am delighted that Mr. Lampropoulos will lead an efficient integration of our companies for the benefit of our employees, physicians, hospitals and the women we serve."

The deal gives Merit clients access to Cianna's wire-free breast localization SAVI SCOUT and SAVI Brachy technologies. The SAVI Brachy platform employs a single entry with expanding catheters to fit the tumor cavity and deliver radiation in the form of interstitial brachytherapy, along with tissue-sparing dosimetry capabilities.

Approved by the FDA in 2014, SCOUT enables doctors to localize a tumor using radar days before surgery, cutting procedure time versus wired localization.

The detector is placed in the target tissue up to seven days before the procedure. During surgery a hand-piece is used to find the detector and audible and visible indicators permit maneuvering to spare healthy tissue while removing the tumor. It is accurate to 1 mm and provides real-time distance measurement.

“I am in a position now where I don't want to do lumpectomies without real-time guidance,” said Dr. Pat Whitworth, breast surgical oncologist and director of the Nashville Breast Center, about the device when it received FDA clearance. “I am confident I'm removing the right tissue and not the tissue I don't need to.”

Since its debut, the device has experienced a revenue growth from $1 million at its debut to a projected $29 million in 2018, with its current estimated market share at approximately 5 percent with no revenues currently outside of the U.S.

“With more than 350 initiations and 45,000 wire-free localizations to date, the SAVI SCOUT is complementary to Merit's strategic biopsy initiatives,” Lampropoulos advised.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED